MedTrace Logo

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2026-06-29

No results posted yet for this study

Summary

This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.

Conditions

  • Bladder Cancer
  • Urothelial Carcinoma (UC)
  • Hematuria
  • Upper Tract Urothelial Cancer

Sponsors & Collaborators

  • Convergent Genomics, Inc.

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2034-12-31
Completion
2034-12-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673016 on ClinicalTrials.gov